Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Michael G. Grey is an entrepreneur and businessperson who founded Mirum Pharmaceuticals, Inc., Reneo Pharmaceuticals, Inc. and Lumena Pharmaceuticals, Inc. and who has been at the helm of 17 different companies. Presently, Mr. Grey holds the position of Executive Chairman at Reneo Pharmaceuticals, Inc., Executive Chairman for Spruce Biosciences, Inc., Chairman of Mirum Pharmaceuticals, Inc., Executive Chairman of Plexium, Inc., Chairman for Sorriso Pharmaceuticals, Inc. and Venture partner at Pappas Capital LLC.

He is also on the board of Biothera, Inc., Horizon Therapeutics Plc and San Diego Venture Group.

In the past Michael G. Grey was Director at Curzion Pharmaceuticals, Inc., President & Chief Operating Officer for Ansan, Inc., Non-Executive Chairman at IDM Pharma, Inc., Executive Chairman for Amplyx Pharmaceuticals, Inc., Independent Director at Ziarco Pharma Ltd., Executive Chairman for Ziarco Group Ltd., President, Chief Executive Officer & Director at Trega Biosciences, Inc., President, Chief Executive Officer & Director at Lumena Pharmaceuticals, Inc., President & Chief Executive Officer of SGX Pharmaceuticals, Inc., President & Chief Operating Officer for Ansan Pharmaceuticals, Inc., President & Chief Executive Officer at Auspex Pharmaceuticals, Inc., President of Biochem Therapeutic, Inc., Vice President-Corporate Development at Glaxo, Inc. and Vice President-Corporate Development for Glaxo Holdings Plc.

He received an undergraduate degree from The University of Nottingham.


Current positions of Michael G. Grey 
NameTitle Since
Horizon Therapeutics Public Limited Company
(Pharmaceuticals)
Lead Independent Director 2012
Mirum Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Chairman 2020
Reneo Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Executive Chairman 2017
Spruce Biosciences, Inc.
(Biotechnology & Medical Research)
Executive Chairman 2022
Plexium, Inc. Executive Chairman 2021
Sorriso Pharmaceuticals, Inc. Chairman 2021
Biothera, Inc. Vice Chairman -
San Diego Venture Group Director -
Pappas Capital LLC Venture partner 2010


Holdings of Michael G. Grey 
NameEquities%Valuation
Mirum Pharmaceuticals, Inc. (MIRM)
(Biotechnology & Medical Research)
382,9481.21%9,106,503 USD
Horizon Therapeutics Public Limited Company (HZNP)
(Pharmaceuticals)
65,3740.029%6,443,261 USD
BioMarin Pharmaceutical Inc. (BMRN)
(Pharmaceuticals)
42,8400.023%3,485,034 USD
Reneo Pharmaceuticals, Inc. (RPHM)
(Biotechnology & Medical Research)
578,8462.37%1,342,923 USD
Mirati Therapeutics, Inc. (MRTX)
(Biotechnology & Medical Research)
5,7310.010%354,118 USD
Spruce Biosciences, Inc. (SPRB)
(Biotechnology & Medical Research)
00.0000%0 USD


Michael G. Grey: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
More news


© 2022 People and Ownership :   
Michael G. Grey : Connections